Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Pharmacogenet Genomics. 2011 Jul;21(7):388–396. doi: 10.1097/FPC.0b013e32834632e4

Table 3.

Stratification analyses between the combined genotypes of MDM4 polymorphisms and SCCHN risk

Variables No. (Case / Control) Combined genotypes (case / control)
OR (95% CI)b
0 risk genotypea 1–3 risk genotypesa

n % n %
Age (years)
 ≤45 153 / 170 28 / 32 18.3 / 18.8 125 / 138 81.7 / 81.2 1.06 (0.59–1.87)
 46–60 525 / 523 108 / 109 20.6 / 20.8 417 / 414 79.4 / 79.2 1.06 (0.77–1.45)
 >60 397 / 386 70 / 87 17.6 / 22.5 327 / 299 82.4 / 77.5 1.41 (0.97–2.05)
Sex
 Female 267 / 253 48 / 52 18.0 / 20.5 219 / 201 82.0 / 79.5 1.31 (0.81–2.09)
 Male 808 / 826 158 / 176 19.6 / 21.3 650 / 650 80.5 / 78.7 1.12 (0.87–1.43)
Smoking status
 Never 299 / 526 55 / 111 18.4 / 21.1 245 / 415 81.6 / 78.9 1.18 (0.82–1.69)
 Ever 776 / 553 151 / 117 19.46 / 21.2 625 / 436 80.54 / 78.8 1.11 (0.84–1.46)
Drinking status
 Never 294 / 468 52 / 102 17.7 / 21.8 242 / 366 82.31 / 78.2 1.29 (0.88–1.87)
 Ever 781 / 611 154 / 126 19.7 / 20.6 627 / 485 80.28 / 79.4 1.09 (0.83–1.44)
a

This represents the number of risk genotypes: rs11801299GG, rs1380576CG+GG, and rs10900598GG.

b

Adjusted for age, sex, smoking status, and alcohol use in a logistic regression model.